weight-loss41.065 min read Less Frequent GLP-1 Shots May Sustain Weight Loss, Small Study Finds
A small study of 30 adults suggests that reducing GLP-1 injections (tirzepatide or semaglutide) to intervals of 2–6 weeks can help maintain weight loss and improve health markers. Participants averaged about 36 weeks on reduced dosing with most keeping BMI stable; four regained some weight (largest gain 8 lb). Experts say tapering isn’t right for everyone and larger trials are needed, but this approach could lower long-term costs and treatment burden when paired with lifestyle changes.
4 hours ago•Source: Healthline
